On the kinetic features of orexin receptor antagonists at orexin receptors, transduction systems and receptor binding
Orexin receptor antagonists are on the market or under development for the treatment of insomnia and a number of other neuropsychiatric disorders. Currently, suvorexant, lemborexant and daridorexant, three dual orexin receptor antagonists (DORAs) have received market approval by regulatory authoriti...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Kirja |
| Julkaistu: |
Elsevier,
2024-06-01T00:00:00Z.
|
| Aiheet: | |
| Linkit: | Connect to this object online. |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Internet
Connect to this object online.3rd Floor Main Library
| Hyllypaikka: |
A1234.567 |
|---|---|
| Nide 1 | Saatavissa |